Smoking Rates Declined Among Those With Depression and Substance Use Disorder 

April 27, 2022 by Alexa Hornbeck
Smoking Rates Declined Among Those With Depression and Substance Use Disorder 
(Photo by Andres Siimon on unsplash)

report released Tuesday from the National Institute on Drug Abuse finds that tobacco smoking rates are decreasing in people with major depression and substance use disorder.

The analysis, published in the Journal of the American Medical Association, reviews data from about 560,000 adults aged 18 and older who participated in the National Survey on Drug Use and Health from 2006 to 2019.

Researchers found that although individuals who had substance use disorder or major depression, or both, were more likely to smoke cigarettes than people without those disorders, there was a past-month smoking rate decline of 13.1% among adults with past-year major depressive episodes and by 8.2% among adults without.

According to the data, the difference in the past-month cigarette smoking among those with versus without past-year major depressive episodes significantly narrowed from 11.5% in 2006 to 6.6% in 2019.

For individuals with past-year substance use disorder, past-month cigarette smoking declined by 10.9% from 2006 to 2019, and 7.8% among adults without. 

For those with both major depression and substance use disorder, past-moth smoking rates decreased by 13.7% during this 14-year period and by 7.6% among adults without either disorder. 

“These declines tell a public health success story … [but] there’s still a lot of work to be done to ensure tobacco use in patients with substance use disorder, depression or other psychiatric conditions continue[s] to decrease,” said Wilson Compton, the senior author of the study and deputy director at NIDA in a written statement

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

April 17, 2024
by Dan McCue
Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

April 16, 2024
by Dan McCue
Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

Biden Administration Announces Partnership With 50 Countries to Stifle Future Pandemics

WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal... Read More

WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the COVID-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will work with the countries to develop better testing, surveillance,... Read More

Are Americans Feeling Like They Get Enough Sleep? Dream On, a New Gallup Poll Says

NEW YORK (AP) — If you're feeling — YAWN — sleepy or tired while you read this and wish you... Read More

NEW YORK (AP) — If you're feeling — YAWN — sleepy or tired while you read this and wish you could get some more shut-eye, you're not alone. A majority of Americans say they would feel better if they could have more sleep, according to a... Read More

News From The Well
scroll top